TrialInternational journal of radiation oncology, biology, physics2021

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.

Umair Mahmood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.